REGISTERED
on 19 Apr 2022
Last Applicant/ Owned by
500 Fairview Avenue North, Suite 600
Seattle
WA
98109
Serial Number
88108651 filed on 07th Sep 2018
Registration Number
6707689 registered on 19th Apr 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
IMMUNOTAC
Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates
First Use Date in General
11th Aug 2021
First Use Date in Commerce
11th Aug 2021
Mark Details
Serial Number
No 88108651
Mark Type
No Service Mark
Attorney Docket Number
No T-4153/2 US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Apr 2022 | REGISTERED-PRINCIPAL REGISTER |
| 17th Mar 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Mar 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 18th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Feb 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th Feb 2022 | SOU EXTENSION 4 GRANTED |
| 17th Feb 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 10th Feb 2022 | USE AMENDMENT FILED |
| 10th Feb 2022 | SOU EXTENSION 4 FILED |
| 10th Feb 2022 | TEAS EXTENSION RECEIVED |